Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Intake | 14 | 2021 | 80 | 2.820 |
Why?
|
| Sarcopenia | 8 | 2021 | 31 | 2.490 |
Why?
|
| Intensive Care Units | 16 | 2021 | 261 | 2.360 |
Why?
|
| Enteral Nutrition | 13 | 2021 | 57 | 2.320 |
Why?
|
| Parenteral Nutrition | 10 | 2021 | 20 | 2.310 |
Why?
|
| Nutritional Status | 14 | 2021 | 56 | 2.300 |
Why?
|
| Critical Care | 8 | 2021 | 118 | 2.230 |
Why?
|
| Critical Illness | 17 | 2021 | 113 | 2.170 |
Why?
|
| Malnutrition | 9 | 2019 | 24 | 2.140 |
Why?
|
| Nutritional Support | 8 | 2021 | 23 | 1.970 |
Why?
|
| Acute Lung Injury | 6 | 2018 | 18 | 1.640 |
Why?
|
| Body Composition | 6 | 2022 | 63 | 1.530 |
Why?
|
| Dietetics | 5 | 2020 | 9 | 1.520 |
Why?
|
| Hypothyroidism | 3 | 2023 | 69 | 1.210 |
Why?
|
| Respiratory Insufficiency | 6 | 2023 | 50 | 1.090 |
Why?
|
| Nutritional Requirements | 7 | 2021 | 16 | 1.050 |
Why?
|
| Humans | 58 | 2023 | 25900 | 1.050 |
Why?
|
| Neoplasms | 3 | 2017 | 220 | 0.990 |
Why?
|
| Respiratory Muscles | 3 | 2021 | 18 | 0.970 |
Why?
|
| Muscle, Skeletal | 7 | 2021 | 378 | 0.940 |
Why?
|
| Blood Glucose | 6 | 2021 | 99 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2022 | 631 | 0.910 |
Why?
|
| Hand Strength | 2 | 2021 | 56 | 0.850 |
Why?
|
| Male | 37 | 2022 | 14176 | 0.790 |
Why?
|
| Female | 37 | 2022 | 14543 | 0.780 |
Why?
|
| Research Design | 2 | 2021 | 176 | 0.750 |
Why?
|
| Nutrition Assessment | 8 | 2019 | 43 | 0.720 |
Why?
|
| Thyroxine | 4 | 2023 | 81 | 0.710 |
Why?
|
| Nutritionists | 2 | 2020 | 2 | 0.700 |
Why?
|
| C-Reactive Protein | 4 | 2016 | 95 | 0.690 |
Why?
|
| Hospitalization | 7 | 2018 | 295 | 0.670 |
Why?
|
| Medical Staff Privileges | 1 | 2020 | 2 | 0.670 |
Why?
|
| Adult | 22 | 2023 | 7517 | 0.670 |
Why?
|
| Cachexia | 2 | 2017 | 11 | 0.660 |
Why?
|
| Prescriptions | 1 | 2020 | 17 | 0.660 |
Why?
|
| Middle Aged | 26 | 2021 | 8556 | 0.630 |
Why?
|
| Muscle Strength | 2 | 2019 | 129 | 0.630 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 847 | 0.610 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 5 | 0.610 |
Why?
|
| Insulin | 4 | 2013 | 89 | 0.610 |
Why?
|
| Triiodothyronine | 3 | 2023 | 92 | 0.580 |
Why?
|
| Underage Drinking | 1 | 2017 | 1 | 0.550 |
Why?
|
| Thyrotropin | 2 | 2020 | 49 | 0.550 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 15 | 0.550 |
Why?
|
| Dietary Proteins | 5 | 2016 | 26 | 0.540 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 25 | 0.530 |
Why?
|
| Prevalence | 8 | 2021 | 431 | 0.530 |
Why?
|
| Personality | 1 | 2017 | 51 | 0.530 |
Why?
|
| Self Report | 1 | 2018 | 207 | 0.530 |
Why?
|
| Smoking | 1 | 2017 | 173 | 0.500 |
Why?
|
| Retrospective Studies | 10 | 2021 | 3342 | 0.500 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 314 | 0.460 |
Why?
|
| Respiration, Artificial | 8 | 2021 | 107 | 0.450 |
Why?
|
| Aged | 20 | 2021 | 8658 | 0.440 |
Why?
|
| Hypoglycemia | 1 | 2013 | 13 | 0.400 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2011 | 3 | 0.370 |
Why?
|
| Prealbumin | 1 | 2011 | 4 | 0.370 |
Why?
|
| APACHE | 6 | 2021 | 27 | 0.360 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 66 | 0.350 |
Why?
|
| Eating | 1 | 2010 | 57 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2010 | 96 | 0.320 |
Why?
|
| Inflammation | 1 | 2011 | 277 | 0.310 |
Why?
|
| Patient Care Team | 1 | 2010 | 113 | 0.310 |
Why?
|
| Body Mass Index | 7 | 2022 | 431 | 0.300 |
Why?
|
| Diet | 1 | 2010 | 214 | 0.290 |
Why?
|
| Adipose Tissue | 2 | 2022 | 71 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 251 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2017 | 127 | 0.270 |
Why?
|
| Affect | 2 | 2018 | 58 | 0.270 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 1083 | 0.270 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 286 | 0.250 |
Why?
|
| Hyperglycemia | 4 | 2013 | 27 | 0.250 |
Why?
|
| Ketone Bodies | 1 | 2005 | 3 | 0.240 |
Why?
|
| Growth | 1 | 2005 | 6 | 0.240 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2005 | 5 | 0.240 |
Why?
|
| Ketosis | 1 | 2005 | 7 | 0.240 |
Why?
|
| Obesity | 4 | 2016 | 292 | 0.230 |
Why?
|
| Epilepsy | 1 | 2005 | 69 | 0.220 |
Why?
|
| Child Development | 1 | 2005 | 69 | 0.220 |
Why?
|
| Pilot Projects | 3 | 2021 | 394 | 0.220 |
Why?
|
| Depression | 2 | 2018 | 410 | 0.220 |
Why?
|
| Length of Stay | 5 | 2014 | 307 | 0.210 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 313 | 0.210 |
Why?
|
| Risk Factors | 4 | 2021 | 2173 | 0.200 |
Why?
|
| Noninvasive Ventilation | 1 | 2023 | 11 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2021 | 893 | 0.200 |
Why?
|
| Maximal Respiratory Pressures | 2 | 2019 | 3 | 0.200 |
Why?
|
| Academies and Institutes | 2 | 2020 | 11 | 0.200 |
Why?
|
| Inpatients | 2 | 2019 | 121 | 0.200 |
Why?
|
| Physicians | 2 | 2018 | 113 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2020 | 118 | 0.190 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 28 | 0.180 |
Why?
|
| Muscles | 1 | 2021 | 50 | 0.180 |
Why?
|
| Sample Size | 1 | 2021 | 17 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2020 | 1686 | 0.180 |
Why?
|
| Child | 3 | 2018 | 1180 | 0.180 |
Why?
|
| Coma | 1 | 2021 | 5 | 0.180 |
Why?
|
| Delirium | 1 | 2021 | 12 | 0.170 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 4633 | 0.170 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 13 | 0.170 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 21 | 0.170 |
Why?
|
| Documentation | 2 | 2018 | 21 | 0.170 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 6 | 0.170 |
Why?
|
| Euthyroid Sick Syndromes | 1 | 2020 | 7 | 0.160 |
Why?
|
| Long-Term Care | 1 | 2020 | 58 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 32 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2013 | 1815 | 0.160 |
Why?
|
| Muscular Atrophy | 2 | 2016 | 12 | 0.160 |
Why?
|
| Medicare | 1 | 2020 | 116 | 0.160 |
Why?
|
| Hospitals | 1 | 2020 | 162 | 0.150 |
Why?
|
| Patients | 1 | 2019 | 32 | 0.150 |
Why?
|
| Overweight | 2 | 2016 | 71 | 0.150 |
Why?
|
| Adolescent | 3 | 2017 | 2070 | 0.150 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 1 | 0.150 |
Why?
|
| Clinical Coding | 1 | 2018 | 4 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2018 | 8 | 0.140 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 12 | 0.140 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 33 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 43 | 0.140 |
Why?
|
| Professional Competence | 1 | 2018 | 38 | 0.140 |
Why?
|
| Fatigue | 1 | 2018 | 56 | 0.140 |
Why?
|
| Emotions | 1 | 2018 | 72 | 0.140 |
Why?
|
| Puberty | 1 | 2017 | 10 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2018 | 58 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2017 | 7 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2016 | 145 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 18 | 0.140 |
Why?
|
| Child Behavior | 1 | 2017 | 28 | 0.130 |
Why?
|
| Internet | 1 | 2018 | 85 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 421 | 0.130 |
Why?
|
| Tomography | 2 | 2013 | 12 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 32 | 0.130 |
Why?
|
| Thyroid Function Tests | 1 | 2016 | 12 | 0.130 |
Why?
|
| Quality of Life | 2 | 2018 | 563 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2020 | 3339 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 43 | 0.130 |
Why?
|
| United States | 2 | 2020 | 1935 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 155 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2016 | 24 | 0.130 |
Why?
|
| Health Surveys | 1 | 2016 | 85 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 34 | 0.130 |
Why?
|
| Point-of-Care Testing | 1 | 2016 | 29 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 9 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 567 | 0.120 |
Why?
|
| Liver Failure | 1 | 2015 | 10 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2016 | 12 | 0.120 |
Why?
|
| Dyspnea | 1 | 2016 | 41 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 328 | 0.120 |
Why?
|
| MEDLINE | 1 | 2015 | 4 | 0.120 |
Why?
|
| Palliative Care | 1 | 2016 | 106 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2016 | 221 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 457 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 43 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 120 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2015 | 403 | 0.110 |
Why?
|
| Logistic Models | 3 | 2016 | 368 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1324 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 415 | 0.100 |
Why?
|
| Pain | 1 | 2016 | 401 | 0.100 |
Why?
|
| Nutrition Therapy | 1 | 2012 | 6 | 0.100 |
Why?
|
| Nausea | 2 | 2010 | 23 | 0.100 |
Why?
|
| Vomiting | 2 | 2010 | 18 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 203 | 0.090 |
Why?
|
| Health Facilities | 1 | 2011 | 25 | 0.090 |
Why?
|
| Cost Savings | 1 | 2010 | 31 | 0.090 |
Why?
|
| Urban Population | 1 | 2011 | 146 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 123 | 0.080 |
Why?
|
| Body Weight | 2 | 2014 | 130 | 0.080 |
Why?
|
| Anorexia | 1 | 2010 | 3 | 0.080 |
Why?
|
| Liver | 1 | 2011 | 150 | 0.080 |
Why?
|
| Drug Stability | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drug Compounding | 1 | 2010 | 3 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1307 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2010 | 31 | 0.080 |
Why?
|
| Drug Monitoring | 1 | 2010 | 11 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 12 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2010 | 23 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2020 | 96 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2010 | 99 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 162 | 0.080 |
Why?
|
| Ventilator Weaning | 1 | 2010 | 34 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 56 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 264 | 0.080 |
Why?
|
| Chicago | 4 | 2019 | 906 | 0.070 |
Why?
|
| Patient Selection | 1 | 2010 | 182 | 0.070 |
Why?
|
| Biomarkers | 1 | 2011 | 536 | 0.070 |
Why?
|
| Nutritional Sciences | 1 | 2008 | 7 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 103 | 0.070 |
Why?
|
| Body Height | 1 | 2005 | 35 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 23 | 0.050 |
Why?
|
| Aging | 1 | 2013 | 1503 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 70 | 0.050 |
Why?
|
| Infant | 1 | 2005 | 503 | 0.050 |
Why?
|
| Cannula | 1 | 2023 | 7 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2005 | 590 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2023 | 14 | 0.050 |
Why?
|
| Thyroid Hormones | 1 | 2023 | 58 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 62 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 24 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 27 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 20 | 0.040 |
Why?
|
| Triiodothyronine, Reverse | 1 | 2020 | 9 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1708 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 335 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 246 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 1929 | 0.040 |
Why?
|
| Societies | 1 | 2018 | 6 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 91 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2018 | 71 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 125 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 22 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 63 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 51 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 61 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 79 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 131 | 0.030 |
Why?
|
| Terminal Care | 1 | 2016 | 26 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2016 | 39 | 0.030 |
Why?
|
| Medical Subject Headings | 1 | 2015 | 1 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 147 | 0.030 |
Why?
|
| Search Engine | 1 | 2015 | 9 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 83 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 12 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 95 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 619 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2016 | 132 | 0.030 |
Why?
|
| Body Fluid Compartments | 1 | 2013 | 5 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 26 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 175 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 57 | 0.030 |
Why?
|
| Minority Groups | 1 | 2013 | 74 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 34 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2013 | 30 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 830 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 254 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 41 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 202 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 111 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 453 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 130 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 450 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2008 | 16 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 127 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 248 | 0.020 |
Why?
|
| Insulin Glargine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 2 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 2006 | 3 | 0.020 |
Why?
|
| Management Service Organizations | 1 | 2006 | 1 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 35 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 143 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2006 | 56 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 314 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2008 | 201 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2008 | 206 | 0.010 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 2 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2004 | 12 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 30 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 337 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 31 | 0.010 |
Why?
|